Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the availability of availability of cancer drugs is maintained during the reorganisation of NHS England.

Whilst this transformation takes place, we will ensure that we continue to evaluate impacts of all kinds and will work collaboratively to ensure continuity of care and that there are no risks to patient safety. Throughout the organisational change, NHS England will continue to undertake all its statutory functions, until parliamentary time allows for legislative changes to be made.

Responsible commissioners will continue to be required to fund medicines for eligible patients in line with recommendations from the National Institute for Health and Care Excellence.